New York, NY -- (SBWIRE) -- 01/22/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Achillion Pharmaceuticals, Inc (NASDAQ:ACHN), Rentech, Inc (NASDAQ:RTK), Tesla Motors Inc (NASDAQ:TSLA), Opko Health Inc (NYSE:OPK)
Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) showed a volume of 2.35 million shares by the end of last trade whereas the average volume of the stock remained 2.27 million shares. The stock opened the session at $4.18 but then moved to $4.20. At that price, the stock showed a positive performance of 1.94%. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV),
Will ACHN Continue To Move Higher? Find Out Here
Rentech, Inc (NASDAQ:RTK) opened the session at $1.94 and closed the session at $2.00. The stock showed a positive performance of 3.09% in previous trading session. Traded with volume of 2.32 million shares in the prior session and the average volume of the stock remained 2.29 million shares. Rentech, Inc. (Rentech) is a provider of clean energy solutions. The Company owns and operates a nitrogen fertilizer plant in East Dubuque, Illinois, that manufactures and sells natural gas-based nitrogen fertilizer products within the corn-belt region in the United States.
For How Long RTK will fight for Profitability? Read This Trend Analysis report
Tesla Motors Inc (NASDAQ:TSLA) opened the session at $171.24 and closed the session at $176.68. The stock showed a positive performance of 3.92% in previous trading session. Traded with volume of 9.75 million shares in the prior session and the average volume of the stock remained 8.91 million shares. The beta of the stock remained 0.34. Tesla Motors, Inc. (Tesla) designs, develops, manufactures and sells electric vehicles and advanced electric vehicle powertrain components.
Why Should Investors Buy TSLA After The Recent Gain? Just Go Here and Find Out
Opko Health Inc (NYSE:OPK) the stock advanced 1.95% and finished the session at $8.89. Traded with volume of 2.30 million shares in the prior session and the average volume of the stock remained 4.89 million shares. The beta of the stock remained 1.00. OPKO Health, Inc. (OPKO) is a multi-national pharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, point-of-care tests, and pharmaceuticals and vaccines.
Will OPK Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)